ArticleFrontiers in oncology2023

QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysis.

David J Reeves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.